Abeona Therapeutics (ABEO) Interest Expenses (2011 - 2026)

Abeona Therapeutics' Interest Expenses history runs 17 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• In Q1 2026, Interest Expenses fell 0.51% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (down 0.51% YoY), while the FY2025 annual figure was $74.9 million, up 1680.47% from the prior year.
• Interest Expenses for Q1 2026 stood at $1.4 million, up from -$1.9 million in the prior quarter.
• The five-year high for Interest Expenses was $11.5 million in Q1 2022, with the low at -$1.9 million in Q4 2025.
• The 5-year median for Interest Expenses is $1.4 million (2023), against an average of $2.9 million.
• The sharpest annual moves came in 2024 and 2025: Interest Expenses surged 892.66% in 2024, then sank 271.53% in 2025.
• Abeona Therapeutics' Interest Expenses stood at $178000.0 in 2022, then tumbled by 38.76% to $109000.0 in 2023, then soared by 892.66% to $1.1 million in 2024, then tumbled by 271.53% to -$1.9 million in 2025, then jumped by 173.11% to $1.4 million in 2026.
• Business Quant data shows ABEO's Interest Expenses at $1.4 million in Q1 2026, -$1.9 million in Q4 2025, and $1.4 million in Q3 2025.